455593536	455593536	CD	B-NP	O
|	|	NN	I-NP	O
GGHAMC	GGHAMC	NN	I-NP	O
|	|	NN	I-NP	O
70754750	70754750	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
641070	641070	CD	B-NP	O
|	|	CC	I-NP	O
3/30/2001	3/30/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/19/2001	1/19/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
SERVICE	SERVICE	NN	B-NP	O
:	:	:	O	O
CHTL	CHTL	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
CENTER	CENTER	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
ASPIRATION	ASPIRATION	NN	B-NP	O
PNEUMONITIS	PNEUMONITIS	NN	I-NP	O
.	.	.	O	O

IDENTIFICATION	IDENTIFICATION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
43	43	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
antiphospholipid	antiphospholipid	JJ	B-NP	O
antibody	antibody	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
recently	recently	RB	B-ADVP	O
discharged	discharge	VBN	B-VP	O
from	from	IN	B-PP	O
Woo	Woo	NNP	B-NP	O
Ackla	Ackla	NNP	I-NP	O
Beth	Beth	NNP	I-NP	O
's	's	POS	B-NP	O
Hospital	Hospital	NNP	I-NP	O
ICU	ICU	NNP	I-NP	O
on	on	IN	B-PP	O
November	November	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
returns	return	VBZ	B-VP	O
for	for	IN	B-PP	O
hypercarbic	hypercarbic	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
presumed	presume	VBD	B-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

HISTORY	HISTORY	NN	B-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
43	43	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
complicated	complicated	JJ	I-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
a	a	DT	B-NP	O
recent	recent	JJ	I-NP	O
long	long	JJ	I-NP	O
hospitalization	hospitalization	NN	I-NP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
month	month	NN	I-NP	O
of	of	IN	B-PP	O
September	September	NNP	B-NP	O
2001	2001	CD	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
ENT	ENT	NN	I-NP	O
service	service	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
lingual	lingual	JJ	B-NP	O
tonsillitis	tonsillitis	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
complicated	complicate	VBN	I-VP	O
by	by	IN	B-PP	O
difficulty	difficulty	NN	B-NP	O
handling	handle	VBG	B-VP	O
secretions	secretion	NNS	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
desaturation	desaturation	NN	B-NP	O
which	which	WDT	B-NP	O
prompted	prompt	VBD	B-VP	O
transfer	transfer	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MICU	MICU	NNP	I-NP	O
on	on	IN	B-PP	O
May	May	NNP	B-NP	O
,	,	,	O	O
2001	2001	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
febrile	febrile	JJ	B-ADJP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
clinda	clinda	NN	B-NP	O
and	and	CC	I-NP	O
levo	levo	NN	I-NP	O
and	and	CC	O	O
intubated	intubate	VBN	B-VP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
acute	acute	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
prolonged	prolonged	JJ	B-NP	O
intubation	intubation	NN	I-NP	O
with	with	IN	B-PP	O
extubation	extubation	NN	B-NP	O
finally	finally	RB	B-ADVP	O
on	on	IN	B-PP	O
January	January	NNP	B-NP	O
.	.	.	O	O

Post	Post	JJ	B-NP	O
extubation	extubation	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
heavily	heavily	RB	I-VP	O
sedated	sedate	VBN	I-VP	O
,	,	,	O	O
with	with	IN	B-PP	O
waxing	wax	VBG	B-VP	O
and	and	CC	I-VP	O
waning	wan	VBG	I-VP	O
alertness	alertness	NN	B-NP	O
,	,	,	O	O
but	but	CC	O	O
gradually	gradually	RB	B-VP	O
became	become	VBD	I-VP	O
more	more	RBR	B-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
commands	command	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Vancor	Vancor	NNP	B-NP	O
on	on	IN	B-PP	O
10/10	10/10	CD	B-NP	O
with	with	IN	B-PP	O
still	still	RB	B-NP	O
some	some	DT	I-NP	O
depressed	depressed	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
mental	mental	JJ	B-NP	O
status	status	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
increased	increase	VBN	I-VP	O
respiratory	respiratory	JJ	B-NP	O
difficulty	difficulty	NN	I-NP	O
and	and	CC	O	O
increased	increase	VBN	B-NP	O
secretions	secretion	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
since	since	IN	B-PP	O
his	his	PRP$	B-NP	O
discharge	discharge	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
became	become	VBD	B-VP	O
acutely	acutely	RB	B-ADJP	O
tachypneic	tachypneic	JJ	I-ADJP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
40s	40	NNS	I-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
dropped	drop	VBD	B-VP	O
into	into	IN	B-PP	O
the	the	DT	B-NP	O
80s	80	NNS	I-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
nonrebreather	nonrebreather	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
mother	mother	NN	I-NP	O
reported	report	VBD	B-VP	O
that	that	IN	B-SBAR	O
his	his	PRP$	B-NP	O
lungs	lung	NNS	I-NP	O
``	``	``	O	O
sounded	sounded	JJ	B-NP	O
junky	junky	NN	I-NP	O
.	.	.	O	O
''	''	''	O	O

He	He	PRP	B-NP	O
spiked	spike	VBD	B-VP	O
a	a	DT	B-NP	O
fever	fever	NN	I-NP	O
.	.	.	O	O

Hypotension	Hypotension	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
systolic	systolic	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
70	70	CD	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
.	.	.	O	O

For	For	IN	B-PP	O
this	this	DT	B-NP	O
reason	reason	NN	I-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Cirygene	Cirygene	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Antiphospholipid	Antiphospholipid	NN	I-NP	O
antibody	antibody	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
2	2	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Status	Status	NNP	I-NP	O
post	post	VBD	B-VP	O
CVA	CVA	NNP	B-NP	O
with	with	IN	B-PP	O
residual	residual	JJ	B-NP	O
right-sided	right-sided	JJ	I-NP	O
weakness	weakness	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Epilepsy	Epilepsy	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	B-protein
4	4	CD	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Noninsulin	Noninsulin	NN	I-NP	I-protein
dependent	dependent	JJ	I-NP	O
diabetes	diabete	NNS	I-NP	O
mellitus	mellitus	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
5	5	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
repair	repair	NN	I-NP	O
in	in	IN	B-PP	O
1996	1996	CD	B-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
6	6	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
Irritable	Irritable	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Gout	Gout	NNP	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	SYM	O	O
8	8	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
History	History	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
clot	clot	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
thrombectomy	thrombectomy	NN	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
lived	live	VBD	B-VP	O
previously	previously	RB	B-ADVP	O
in	in	IN	B-PP	O
a	a	DT	B-NP	O
group	group	NN	I-NP	O
home	home	NN	I-NP	O
and	and	CC	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nonsmoker	nonsmoker	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
close	close	JJ	I-NP	O
relationship	relationship	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
mother	mother	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Temperature	Temperature	NN	B-NP	O
103.2	103.2	CD	I-NP	O
,	,	,	O	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
100	100	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
101/40	101/40	CD	I-NP	O
.	.	.	O	O

Vent	Vent	NNP	B-NP	O
Settings	Setting	NNPS	I-NP	O
:	:	:	O	O
SIMV	SIMV	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
20	20	CD	B-NP	O
on	on	IN	B-PP	O
100	100	CD	B-NP	O
%	%	NN	I-NP	O
FIO2	FIO2	NN	I-NP	O
.	.	.	O	O

Arterial	Arterial	JJ	B-NP	B-protein
blood	blood	NN	I-NP	I-protein
gases	gas	NNS	I-NP	I-protein
-	-	HYPH	O	O
pH	pH	NN	B-NP	O
7.4	7.4	CD	I-NP	O
,	,	,	O	O
pCO2	pCO2	NN	B-NP	O
44	44	CD	I-NP	O
,	,	,	O	O
PO2	PO2	NN	B-NP	O
120	120	CD	I-NP	O
.	.	.	O	O

Generally	Generally	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
was	be	VBD	B-VP	O
an	an	DT	B-NP	O
intubated	intubated	JJ	I-NP	O
,	,	,	I-NP	O
sedated	sedate	VBN	I-NP	O
man	man	NN	I-NP	O
who	who	WP	B-NP	O
appeared	appear	VBD	B-VP	O
comfortable	comfortable	JJ	B-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Exam	Exam	NN	B-NP	O
unremarkable	unremarkable	JJ	B-ADJP	O
.	.	.	O	O

NECK	NECK	NN	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
jugular	jugular	JJ	B-NP	O
venous	venous	JJ	I-NP	O
distention	distention	NN	I-NP	O
or	or	CC	I-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

HEART	HEART	NN	B-NP	O
:	:	:	O	O
Regular	Regular	JJ	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
.	.	.	O	O

LUNGS	LUNGS	NN	B-NP	O
:	:	:	O	O
Bronchial	Bronchial	JJ	B-NP	O
breath	breath	NN	I-NP	O
sounds	sound	VBZ	B-VP	O
bilaterally	bilaterally	RB	B-ADVP	O
,	,	,	O	O
right	right	RB	B-ADVP	O
greater	great	JJR	I-ADVP	O
than	than	IN	B-PP	O
left	left	JJ	B-ADJP	O
,	,	,	O	O
decreased	decrease	VBD	B-VP	O
air	air	NN	B-NP	O
entry	entry	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	NN	I-NP	O
.	.	.	O	O

ABDOMEN	ABDOMEN	NN	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
nondistended	nondistended	JJ	I-NP	O
,	,	,	I-NP	O
normoactive	normoactive	JJ	I-NP	O
bowel	bowel	NN	I-NP	O
sounds	sound	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
rebound	rebound	NN	I-NP	O
or	or	CC	I-NP	O
guarding	guarding	NN	I-NP	O
.	.	.	O	O

EXTREMITIES	EXTREMITIES	NNS	B-NP	O
:	:	:	O	O
Warm	Warm	NN	B-NP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
distal	distal	JJ	I-NP	O
pulses	pulse	NNS	I-NP	O
.	.	.	O	O

LAB	LAB	NN	B-NP	B-protein
STUDIES	STUDIES	VBZ	B-VP	O
ON	ON	NN	B-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
156	156	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
5	5	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
117	117	CD	I-NP	O
,	,	,	O	O
bicarb	bicarb	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
49	49	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
2.4	2.4	CD	I-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
171	171	CD	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
34.5	34.5	CD	I-NP	I-protein
,	,	,	O	O
white	white	JJ	B-NP	O
count	count	NN	I-NP	O
16.05	16.05	CD	I-NP	O
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
226	226	CD	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
-	-	HYPH	B-NP	O
1.5	1.5	CD	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
SYSTEMS	SYSTEMS	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
arrived	arrive	VBD	B-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Anall	Anall	NNP	I-NP	O
Health	Health	NNP	I-NP	O
intubated	intubate	VBD	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
hemorrhage	hemorrhage	NN	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
more	more	RBR	I-VP	O
easily	easily	RB	I-VP	O
extubated	extubate	VBN	I-VP	O
on	on	IN	B-PP	O
10/27/01	10/27/01	CD	B-NP	O
and	and	CC	O	O
after	after	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
exhibit	exhibit	VB	I-VP	O
and	and	CC	O	O
inability	inability	NN	B-NP	O
to	to	TO	B-VP	O
handle	handle	VB	I-VP	O
his	his	PRP$	B-NP	O
secretions	secretion	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
did	do	VBD	B-VP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
maintain	maintain	VBP	B-VP	O
good	good	JJ	B-NP	O
saturations	saturation	NNS	I-NP	O
on	on	IN	B-PP	O
progressively	progressively	RB	B-ADVP	O
diminishing	diminish	VBG	B-VP	O
amounts	amount	NNS	B-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
via	via	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
an	an	DT	B-NP	O
adequate	adequate	JJ	I-NP	O
oxygen	oxygen	NN	I-NP	O
saturation	saturation	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
underwent	undergo	VBD	B-VP	O
placement	placement	NN	B-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
PEG	PEG	NN	I-NP	O
tube	tube	NN	I-NP	O
on	on	IN	B-PP	O
2/3/01	2/3/01	NN	B-NP	O
in	in	IN	B-SBAR	O
order	order	NN	O	O
to	to	TO	B-VP	O
feed	feed	VB	I-VP	O
him	him	PRP	B-NP	O
without	without	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
speech	speech	NN	I-NP	O
and	and	CC	O	O
swallow	swallow	VB	B-VP	O
study	study	NN	B-NP	O
showed	show	VBD	B-VP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
problems	problem	NNS	B-NP	O
with	with	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
managed	manage	VBN	I-VP	O
with	with	IN	B-PP	O
metoprolol	metoprolol	NN	B-NP	O
and	and	CC	O	O
Captopril	Captopril	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
up	up	RP	B-PRT	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hypotension	hypotension	NN	I-NP	O
that	that	WDT	B-NP	O
characterized	characterize	VBD	B-VP	O
his	his	PRP$	B-NP	O
presentation	presentation	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
recur	recur	VB	I-VP	O
at	at	IN	B-ADVP	O
all	all	DT	I-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Infectious	Infectious	JJ	B-NP	O
Disease	Disease	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
to	to	TO	B-VP	O
complete	complete	VB	I-VP	O
a	a	DT	B-NP	O
21	21	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
admission	admission	NN	I-NP	O
but	but	CC	O	O
had	have	VBD	B-VP	O
ongoing	ongoing	JJ	B-NP	O
fever	fever	NN	I-NP	O
and	and	CC	O	O
positive	positive	JJ	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
for	for	IN	B-PP	O
Staph	Staph	NNP	B-NP	O
epi	epi	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
completed	complete	VBD	B-VP	O
an	an	DT	B-NP	O
additional	additional	JJ	I-NP	O
seven	seven	CD	I-NP	O
days	day	NNS	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Flagyl	Flagyl	NN	B-NP	O
for	for	IN	B-PP	O
seven	seven	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
aspiration	aspiration	NN	I-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
briefly	briefly	RB	I-VP	O
also	also	RB	I-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
ampicillin	ampicillin	NN	B-NP	O
early	early	RB	B-ADVP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
he	he	PRP	B-NP	O
completed	complete	VBD	B-VP	O
his	his	PRP$	B-NP	O
28	28	CD	I-NP	O
day	day	NN	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vanco	vanco	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
defervesced	defervesce	VBN	I-VP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
infection	infection	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
to	to	TO	B-PP	O
Jeunerah	Jeunerah	NNP	B-NP	O
Memorial	Memorial	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
anticoagulated	anticoagulate	VBD	B-VP	O
with	with	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
however	however	RB	B-ADVP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
heparin	heparin	NN	B-NP	O
so	so	IN	B-SBAR	O
that	that	IN	I-SBAR	O
he	he	PRP	B-NP	O
might	might	MD	B-VP	O
be	be	VB	I-VP	O
more	more	RBR	B-ADJP	O
able	able	JJ	I-ADJP	O
to	to	TO	B-VP	O
get	get	VB	I-VP	O
procedures	procedure	NNS	B-NP	O
if	if	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
continued	continue	VBD	B-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
easily	easily	RB	I-NP	O
managed	manage	VBN	I-NP	O
PTT	PTT	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
his	his	PRP$	B-NP	O
PEG	PEG	NN	I-NP	O
tube	tube	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
and	and	CC	I-NP	O
Coumadin	Coumadin	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
transitioned	transitione	VBN	I-VP	O
to	to	TO	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
alone	alone	RB	B-ADVP	O
once	once	RB	O	O
his	his	PRP$	B-NP	O
INR	INR	NN	I-NP	B-protein
is	be	VBZ	B-VP	O
therapeutic	therapeutic	JJ	B-ADJP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Neuro	Neuro	NNP	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBN	B-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
seizures	seizure	NNS	I-NP	O
medicines	medicine	NNS	I-NP	O
-	-	HYPH	B-NP	O
Valproic	Valproic	JJ	I-NP	O
Acid	Acid	NN	I-NP	O
and	and	CC	I-NP	O
Neurontin	Neurontin	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
seizure	seizure	NN	B-NP	O
activity	activity	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
mental	mental	JJ	I-NP	O
status	status	NN	I-NP	O
improved	improve	VBN	B-VP	O
progressively	progressively	RB	B-ADVP	O
after	after	IN	B-PP	O
intubation	intubation	NN	B-NP	O
,	,	,	O	O
however	however	RB	B-ADVP	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
deficits	deficit	NNS	B-NP	O
in	in	IN	B-PP	O
swallowing	swallow	VBG	B-VP	O
,	,	,	O	O
significant	significant	JJ	B-ADJP	O
enough	enough	RB	I-ADJP	O
to	to	TO	B-VP	O
require	require	VB	I-VP	O
the	the	DT	B-NP	O
PEG	PEG	NN	I-NP	O
tube	tube	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
awake	awake	JJ	B-ADJP	O
and	and	CC	O	O
alert	alert	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
interactive	interactive	JJ	I-ADJP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Disposition	Disposition	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
felt	feel	VBN	I-VP	O
to	to	TO	I-VP	O
benefit	benefit	VB	I-VP	O
from	from	IN	B-PP	O
acute	acute	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
conclusion	conclusion	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
to	to	TO	B-VP	O
enjoy	enjoy	VB	I-VP	O
aggressive	aggressive	JJ	B-NP	O
PT	PT	NN	I-NP	O
and	and	CC	I-NP	O
OT	OT	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Albuterol	Albuterol	NN	B-NP	O
2.5	2.5	CD	B-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBD	B-VP	O
q.	q.	NN	B-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Captopril	Captopril	NNP	B-NP	O
18.75	18.75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Colchicine	Colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
insulin	insulin	NN	I-NP	I-protein
32	32	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
q.a.m.	q.a.m.	RB	B-ADVP	O
,	,	,	O	O
32	32	CD	B-NP	O
units	unit	NNS	I-NP	O
q.p.m.	q.p.m.	RB	B-ADVP	O
,	,	,	O	O
sliding	slide	VBG	B-VP	O
scale	scale	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
200	200	CD	B-NP	O
give	give	VB	B-VP	O
0	0	CD	B-NP	O
units	unit	NNS	I-NP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
201-250	201-250	CD	I-NP	O
give	give	VBP	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
regular	regular	JJ	B-NP	O
insulin	insulin	NN	I-NP	O
subcu	subcu	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
251-300	251-300	CD	I-NP	O
give	give	VBP	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
subcu	subcu	NN	B-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
301-350	301-350	CD	I-NP	O
give	give	VBP	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
regular	regular	JJ	B-NP	O
subcu	subcu	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
351-400	351-400	CD	I-NP	O
give	give	VBP	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
regular	regular	JJ	B-NP	O
subcu	subcu	NN	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
greater	great	JJR	B-NP	O
than	than	IN	I-NP	O
400	400	CD	I-NP	O
please	please	NN	I-NP	O
call	call	NN	I-NP	O
MD	MD	NNP	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Nystatin	Nystatin	NN	B-NP	O
suspension	suspension	NN	I-NP	O
10	10	CD	I-NP	O
ml	ml	NN	I-NP	O
swish	swish	NN	I-NP	O
and	and	CC	O	O
spit	spit	NN	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
Ocean	Ocean	NNP	B-NP	O
Spray	Spray	NNP	I-NP	O
two	two	CD	B-NP	O
sprays	spray	NNS	I-NP	O
nasally	nasally	RB	B-ADVP	O
q.i.d.	q.i.d.	RB	I-ADVP	O
,	,	,	O	O
Carafate	Carafate	NNP	B-NP	O
1	1	CD	I-NP	O
gram	gram	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.i.d.	q.i.d.	FW	I-ADVP	O
,	,	,	O	O
Valproic	Valproic	NNP	B-NP	O
Acid	Acid	NNP	I-NP	O
750	750	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
5	5	CD	I-NP	O
ml	ml	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Atrovent	Atrovent	NNP	B-NP	O
nebulizer	nebulizer	NN	I-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
nebulized	nebulize	VBN	B-VP	O
q.i.d.	q.i.d.	NNP	B-NP	O
,	,	,	O	O
Neurontin	Neurontin	NNP	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
p.NG	p.NG	NN	I-NP	O
tube	tube	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Risperdal	Risperdal	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.NG	p.NG	NN	I-NP	O
tube	tube	NN	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Myconazole	Myconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
apply	apply	RB	B-ADVP	O
to	to	TO	B-PP	O
affected	affect	VBN	B-NP	O
areas	area	NNS	I-NP	O
,	,	,	O	O
carnitine	carnitine	NN	B-NP	O
300	300	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
Nizoral	Nizoral	JJ	B-NP	O
shampoo	shampoo	NN	I-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
topically	topically	RB	B-ADVP	O
q.d.	q.d.	RB	I-ADVP	O
,	,	,	O	O
Lovenox	Lovenox	NNP	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
subcu	subcu	NN	I-NP	O
q.12.h	q.12.h	NN	I-NP	O
.	.	.	O	O

INSTRUCTIONS	INSTRUCTIONS	NNS	B-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
discontinue	discontinue	VBP	B-VP	O
once	once	RB	B-ADVP	O
INR	INR	NN	B-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
,	,	,	O	O
tube	tube	NN	B-NP	O
feeds	feed	VBZ	B-VP	O
full	full	JJ	B-NP	O
strength	strength	NN	I-NP	O
Jevity	Jevity	NN	I-NP	O
plus	plus	CC	O	O
30	30	CD	B-NP	O
cc/hr	cc/hr	NN	I-NP	O
advancing	advance	VBG	B-VP	O
rate	rate	NN	B-NP	O
to	to	TO	B-PP	O
90	90	CD	B-NP	O
cc/hr	cc/hr	NN	I-NP	O
q.	q.	NN	I-NP	O
8h	8h	NN	I-NP	O
.	.	.	O	O

if	if	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
ABRAM	ABRAM	NNP	B-NP	O
SYLVIS	SYLVIS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
IL19	IL19	NNP	I-NP	B-protein
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ELISHA	ELISHA	NNP	B-NP	O
C.	C.	NNP	I-NP	O
METTS	METTS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
TT60	TT60	NNP	I-NP	O
SF119/237550	SF119/237550	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
9498	9498	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

MDRZSD54TG	MDRZSD54TG	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
4/16/01	4/16/01	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
4/16/01	4/16/01	CD	B-NP	O
CC	CC	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

DEAA	DEAA	NN	B-NP	B-protein
/	/	SYM	I-NP	O
MEMORIAL	MEMORIAL	NN	I-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O

